# OnCo record zai-lab (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/zai-lab/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "zai-lab" ;
  schema:name "Zai Lab"@en ;
  schema:alternateName "再鼎医药"@en ;
  schema:description "Zai Lab is the in-licensing pioneer that brings Western cancer drugs to China (niraparib, zanidatamab, repotrectinib, Tumour Treating Fields) and now exports its own bispecific and ADC assets."@en ;
  schema:url <https://onco.cc/companies/zai-lab/>, <https://www.zailaboratory.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.zailaboratory.com/> ;
  onco:tag "china" ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:drugs <https://onco.cc/drugs/niraparib/>, <https://onco.cc/drugs/zanidatamab/>, <https://onco.cc/drugs/repotrectinib/>, <https://onco.cc/drugs/optune/>, <https://onco.cc/drugs/zl-1310/> ;
  onco:companies <https://onco.cc/companies/gsk/>, <https://onco.cc/companies/jazz/>, <https://onco.cc/companies/zymeworks/>, <https://onco.cc/companies/novocure/>, <https://onco.cc/companies/medilink/> ;
  onco:trials <https://onco.cc/trials/nct06885281/> ;
  onco:people <https://onco.cc/people/du-samantha/> .
